中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2014年
24期
80-82
,共3页
环磷腺苷葡胺%美多心安%扩张型心肌病
環燐腺苷葡胺%美多心安%擴張型心肌病
배린선감포알%미다심안%확장형심기병
Meglumine adenosine cyclophosphate%Metoprolol%Dilated cardiomyopathy
目的：分析环磷腺苷葡胺联合美多心安治疗扩张型心肌病的疗效。方法将80例扩张型心肌病患者随机分为两组各40例，对照组给予美多心安治疗，治疗组给予环磷腺苷葡胺联合美多心安治疗。结果治疗组治疗总有效率显著高于对照组，心功能改善情况明显优于对照组（P<0.05）。结论环磷腺苷葡胺联合美多心安治疗扩张型心肌病疗效显著。
目的：分析環燐腺苷葡胺聯閤美多心安治療擴張型心肌病的療效。方法將80例擴張型心肌病患者隨機分為兩組各40例，對照組給予美多心安治療，治療組給予環燐腺苷葡胺聯閤美多心安治療。結果治療組治療總有效率顯著高于對照組，心功能改善情況明顯優于對照組（P<0.05）。結論環燐腺苷葡胺聯閤美多心安治療擴張型心肌病療效顯著。
목적：분석배린선감포알연합미다심안치료확장형심기병적료효。방법장80례확장형심기병환자수궤분위량조각40례，대조조급여미다심안치료，치료조급여배린선감포알연합미다심안치료。결과치료조치료총유효솔현저고우대조조，심공능개선정황명현우우대조조（P<0.05）。결론배린선감포알연합미다심안치료확장형심기병료효현저。
Objective To analyze the effect of meglumine adenosine cyclophosphate combined with metoprolol in dilated cardiomyopathy. Methods 80 cases of patients with dilated cardiomyopathy were randomly divided into two groups of 40 cases,the control group were given metoprolol treatment,the treatment group was given meglumine adenosine cyclophosphate combined with metoprolol treatment. Results The treatment group total effective rate was significantly higher than that of the control group,the improvement of heart function was significantly better than the control group (P<0.05). Conclusion Meglumine adenosine cyclophosphate combined with metoprolol in dilated cardiomyopathy with significant curative effect.
